The Advanced Coronary Treatment (ACT) Foundation is a Canadian non-profit organization based in Ottawa, Ontario.
Organization
| Name | Position | Notes |
|---|---|---|
| Michael Austin | President, Board Chair, National Medical Director[1] | University of Ottawa, Ottawa Hospital, Thunder Bay Regional Health Sciences Centre |
Funding
Current and former corporate funding parters of The ACT Foundation include:[2][3][4][5]
- Amgen
- Astra Pharma
- AstraZeneca
- Aventis Pharma
- Bayer
- Hoechst Marion Roussel
- Merck
- Parke-Davis
- Pfizer
- Pharmacia
External links
Experience | Dr. Michael Austin. LinkedIn. Retrieved May 29, 2023, from https://www.linkedin.com/in/dr-michael-austin-176534a/details/experience/ ↩︎
Our National Health Partners. The ACT Foundation. Retrieved January 24, 2023, from https://web.archive.org/web/20230124091435/https://actfoundation.ca/about-act/our-national-health-partners/ ↩︎
Home. The ACT Foundation. Retrieved October 9, 1999, from http://archive.today/1999.10.09-220841/http://www.actfoundation.ca/ ↩︎
Home. The ACT Foundation. Retrieved June 4, 2001, from https://web.archive.org/web/20010604155535/http://actfoundation.ca/main.html ↩︎
Home. The ACT Foundation. Retrieved June 4, 2002, from http://archive.today/2002.06.04-050606/http://www.actfoundation.ca/main.html ↩︎
